No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
CN Stock MarketDetailed Quotes
301089 Tuoxin Pharmaceutical Group
- 28.52
- -0.97-3.29%
Market Closed Jan 7 15:00 CST
3.61BMarket Cap-49.60P/E (TTM)
29.35High28.01Low41.77KlotVolume29.05Open29.49Pre Close118.93MTurnover4.59%Turnover Ratio14.85P/E (Static)126.54MShares55.4352wk High2.30P/B2.59BFloat Cap25.9552wk Low35.39Limit Up90.98MShs Float229.25Historical High23.59Limit Down4.54%Amplitude24.35Historical Low0.25Dividend TTM28.47Avg Price25.11KlotAsk0.88%Div YieldTTM100Lot Size14.48KlotBid
Intraday
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Tuoxin Pharmaceutical: Report for the third quarter of 2024
The 37.7465 million restricted shares of Tus Pharmaceuticals (301089.SZ) will be listed and traded on October 28.
In the announcement of Taixin Pharmaceutical (301089.SZ), the number of shares issued before the initial public offering has been made public...
There is a risk of diffusion! WHO has launched a global strategic preparedness, causing a sharp rise in monkeypox concept stocks.
A new strain has emerged
Tuoxin Pharmaceutical Group: Half-year report for the year 2024.
Tuoxin Pharmaceutical Group: Summary of Half-Year Report in 2024.
Express News | Tuoxin Pharmaceutical: The net income for the first half of 2024 was a loss of 1.7793 million yuan.
